The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rhinaspray 21 micrograms per metered dose, Nasal Spray Solution

Opella Healthcare France SAS T/A SanofiPA23180/021/001

Main Information

Trade NameRhinaspray 21 micrograms per metered dose, Nasal Spray Solution
Active SubstancesIpratropium bromide
Dosage FormNasal spray, solution
Licence HolderOpella Healthcare France SAS T/A Sanofi
Licence NumberPA23180/021/001

Group Information

ATC CodeR01AX Other nasal preparations
R01AX03 ipratropium bromide


License statusAuthorised
Licence Issued21/03/1997
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back